Snowball logo
logo
STMN_logo

Straumann Holding AG

Fr102.05-Fr0.70  (0.68%)
Estimate
P/E
45.8
EPS
2.23
Beta
1.376
Forecast
P/E (FWD)
27.3
EPS (FWD)
3.74
Dividends
Dividend yield
0.98%
Annual payout
Fr1.00
Next ex. div date
April 21, 27
Payout
77.2%
Div.growth, 5y
10.56%
Dividend growth streak
5 y
Div.rating
About the company
Ticker
STMN
ISIN
CH1175448666
Country
Switzerland
Sector (GICS)
Healthcare
Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Frequently asked questions

What sector does Straumann Holding AG (STMN) operate in?

Straumann Holding AG belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.

What is Straumann Holding AG (STMN) current stock price?

As of the latest data, Straumann Holding AG stock price is CHF 102.05, with a previous close of CHF 102.75. Straumann Holding AG lost -CHF 0.70 in the last trading session, representing a -0.68% loss.

What is Straumann Holding AG (STMN) current market capitalization?

Straumann Holding AG market cap is approximately 16.27 billion.

What is Straumann Holding AG (STMN) Earnings Per Share (EPS)?

The trailing EPS is CHF 2.23, and the forward EPS is CHF 3.74.

What is Straumann Holding AG (STMN) Price-to-Earnings (P/E) ratio?

Straumann Holding AG current P/E ratio is 45.76, with a forward P/E of 27.29.

Does Straumann Holding AG (STMN) pay dividends?

Yes. Straumann Holding AG pays annual dividends with an annualized yield of 0.98% and an estimated annual payout of CHF 1.00 per share.

When is the next ex-dividend date for Straumann Holding AG (STMN)?

The next ex-dividend date is scheduled for April 21, 2027.

When is Straumann Holding AG (STMN) next earnings report?

Straumann Holding AG is expected to release its next earnings report on June 30, 2026.

What is Straumann Holding AG (STMN) beta (volatility) score?

Straumann Holding AG has a beta of 1.376, suggesting it is more volatile than the market.